Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial (Q40275085)
Jump to navigation
Jump to search
scientific article published on October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial |
scientific article published on October 2006 |
Statements
1 reference
Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial (English)
1 reference
Edwin Cook
1 reference
Sue Leurgans
1 reference
Elizabeth Berry-Kravis
1 reference
Sue Ellen Krause
1 reference
Sandra S Block
1 reference
Steve Guter
1 reference
Joanne Wuu
1 reference
Penelope Decle
1 reference
Kristina Potanos
1 reference
Jeff Salt
1 reference
Dominick Maino
1 reference
Dahlia Weinberg
1 reference
Rebecca Lara
1 reference
Tristan Jardini
1 reference
Jennifer Cogswell
1 reference
Steven A Johnson
1 reference
Randi Hagerman
1 reference
1 October 2006
1 reference
1 reference